VANCOUVER, Oct. 30, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture ("JV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results